miR-486-5p: A Prognostic Biomarker for Chronic Myeloid Leukemia

miR-486-5p: A Prognostic Biomarker for Chronic Myeloid Leukemia

Bibliographic Details
Main Authors:	Anuupama Suchiita, Sameer Ahmad Guru, Prasant Yadav, Mirza Masroor, Amit Samadhiya, Namrata Bhutani, Naresh Gupta, Richa Gupta, Alpana Saxena
Format:	Article
Language:	English
Published:	American Chemical Society 2021-03-01
Series:	ACS Omega
Online Access:	https://doi.org/10.1021/acsomega.1c00035

Similar Items

PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India
by: Sameer Ahmad Guru, et al.
Published: (2017-10-01)

Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
by: Sameer Ahmad Guru, et al.
Published: (2022-04-01)

Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival
by: Sameer Ahmad Guru, et al.
Published: (2022-04-01)

Harmony Within: Unravelling the Microbiome–Immune System Symbiosis for Health
by: Anuupama Suchiita, et al.
Published: (2025-01-01)

P486: CD9 MARKS DIFFERENTIATION AND ANTI-TUMOR IMMUNITY IN PEDIATRIC ACUTE MYELOID LEUKEMIA
by: Y. Xu, et al.
Published: (2022-06-01)

MiR-486-5p inhibits the proliferation of leukemia cells and induces apoptosis through targeting FOXO1
by: Hui Liu, et al.
Published: (2023-12-01)

Pediatric Chronic Myeloid Leukemia Presenting in a Mixed Phenotypic Blast Crisis: A Rare Occurrence
by: Jenna Bhattacharya, et al.
Published: (2019-08-01)

miR-486 is potentially associated with the occurrence of OSAHS comlicated with secondary polycythemia
by: SHI Xue-feng, SUN Ze-rui, HE Xiang, JIE You-bang, GU Yu-hai, DUO Jie
Published: (2022-08-01)

Trisomy Chromosome 6 as a Sole Cytogenetic Abnormality in Acute Myeloid Leukemia
by: Monika Gupta, et al.
Published: (2015-02-01)

Clinical implications of cytosine deletion of exon 5 of P53 gene in non small cell lung cancer patients
by: Rashid Mir, et al.
Published: (2016-01-01)

MiR-486 regulates lactation and targets the PTEN gene in cow mammary glands.
by: Dan Li, et al.
Published: (2015-01-01)

Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.
by: Hui Chen, et al.
Published: (2015-01-01)

Renal tuberculosis in an imatinib-treated chronic myeloid leukemia
by: Abhilash Chandra, et al.
Published: (2020-04-01)

Downregulation of KIAA1199 by miR‐486‐5p suppresses tumorigenesis in lung cancer
by: Anqi Wang, et al.
Published: (2020-08-01)

Down-regulation of miR-486-5p expression inhibits the proliferation and invasion of human extravillous trophoblasts, and decreased peripheral plasma miR-486-5p level is associated with human early pregnancy loss
by: Gu Yan, et al.
Published: (2023-09-01)

The Molecular Pathogenesis of Tumor-Suppressive <i>miR-486-5p</i> and <i>miR-486-3p</i> Target Genes: <i>GINS4</i> Facilitates Aggressiveness in Lung Adenocarcinoma
by: Yuya Tomioka, et al.
Published: (2023-07-01)

Downregulation of miR-31, miR-155, and miR-564 in chronic myeloid leukemia cells.
by: Oshrat Hershkovitz Rokah, et al.
Published: (2012-01-01)

P540: RESULTS FROM A PHASE 1 CLINICAL STUDY OF THE ALL-ORAL REGIMEN OF CC-486 AND VENETOCLAX FOR RELAPSED AND REFRACTORY ACUTE MYELOID LEUKEMIA (AML)
by: Maria Amaya, et al.
Published: (2023-08-01)

Computer processor unit 486
by: Universiti Teknologi Malaysia. Perpustakaan
Published: (1989)

MiR-486-3p and MiR-938—Important Inhibitors of Pacemaking Ion Channels and/or Markers of Immune Cells
by: Abimbola J Aminu, et al.
Published: (2021-12-01)

mir210 and BCL2 Expressions in Patients with Acute Myeloid Leukemia
by: Handenur GÖKTAN, et al.
Published: (2022-08-01)

Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men
by: Wataru eAoi, et al.
Published: (2013-04-01)

Clinical value of peripheral blood miR-21 and miR-486 combined with CT forearly cancer diagnosis in pulmonary nodulessmoking
by: Zheng Wang, et al.
Published: (2024-09-01)

Lidocaine promotes fibroblast proliferation after thermal injury via up‐regulating the expression of miR‐663 and miR‐486
by: Sheng‐Gang Wu, et al.
Published: (2020-04-01)

How I Manage Patients with Chronic Myeloid Leukemia (CML): Perspectives from Clinical Practice
by: Guru Murthy GS
Published: (2022-03-01)

Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
by: Tathagata Chatterjee, et al.
Published: (2013-06-01)

Evaluation of the mir-126, mir-182, and mir-486-5p Expression Signature of Head and Neck Squamous Cell Carcinomas and Lung Squamous Cell Carcinomas
by: Gizem ISSIN, et al.
Published: (2021-05-01)

Novel targeted therapies in chronic myeloid leukemia
by: Muhammad Sameer Ashaq, et al.
Published: (2024-12-01)

Myeloid Sarcoma Presenting as Nasal and Orbital Mass: An Initial Manifestation of an Acute Myeloid Leukaemia
by: Amita Jain Gupta, et al.
Published: (2017-07-01)

miR-101 suppresses the development of MLL-rearranged acute myeloid leukemia
by: Estrella Gonzales-Aloy, et al.
Published: (2019-07-01)

MIR retrotransposons link the epigenome and the transcriptome of coding genes in acute myeloid leukemia
by: Aristeidis G. Telonis, et al.
Published: (2022-10-01)

Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia
by: Piqiang Zhang, et al.
Published: (2020-09-01)

Global proteomics dataset of miR-126 overexpression in acute myeloid leukemia
by: Erwin M. Schoof, et al.
Published: (2016-12-01)

P486: REAL-WORLD EFFECTIVENESS AND SAFETY OF CPX-351 IN PATIENTS AGED <60 AND ≥60 YEARS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA: CREST-UK POST-HOC ANALYSIS
by: Priyanka Mehta, et al.
Published: (2023-08-01)

Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance
by: Lianjun Zhang, et al.
Published: (2021-10-01)

MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients.
by: Loredan S Niculescu, et al.
Published: (2015-01-01)

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
by: Fayyad-Kazan Hussein, et al.
Published: (2013-02-01)

miR-486 Promotes the Invasion and Cell Cycle Progression of Ovarian Cancer Cells by Targeting CADM1
by: Chenyang Li, et al.
Published: (2021-01-01)

Isolated leukemia cutis as extramedullary relapse of acute myeloid leukemia
by: Farinoosh Dadrass, et al.
Published: (2022-08-01)

Association between expression level of the miR-320, miR-182, miR-223 and miR-486 and body composition among young Polish female volleyball players
by: Paulina Pruszkowska, et al.
Published: (2024-07-01)